Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 3Breast 3Classical hematology 2Plasma cell 1Other 1Myeloid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Myelodysplastic Syndromes 5Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Vitamin D Deficiency 1Ovarian Neoplasms 1Osteoporosis 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Hematologic Diseases 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1Anemia, Aplastic 1

Interventions

Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vitamin D Deficiency × Cholecalciferol × Myeloid × Clear all
NCT03176849 2020-11-17

A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT

Phoenix Children's Hospital

Phase 4 Completed
49 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Hematologic Diseases, Myelodysplastic Syndromes, Neoplasms, Vitamin D Deficiency, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡